{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:37:15Z","timestamp":1771659435120,"version":"3.50.1"},"reference-count":86,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/13543776.2023.2203814","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T11:29:30Z","timestamp":1681558170000},"page":"151-168","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Antimalarial drugs: what\u2019s new in the patents?"],"prefix":"10.1080","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-4058","authenticated-orcid":false,"given":"Elizabeth A.","family":"Lopes","sequence":"first","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-9353","authenticated-orcid":false,"given":"Maria M. M.","family":"Santos","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-1254","authenticated-orcid":false,"given":"Mattia","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"cit0001","unstructured":"WHO. World malaria report 2022. World Health Organization; 2022."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13412-x"},{"key":"cit0003","first-page":"219","volume-title":"Antiprotozoal drug development and delivery","author":"Lopes EA","year":"2022"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.091208.073403"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2018.04.003"},{"key":"cit0006","unstructured":"Lifecycle of malaria parasite: mMV medicines for malaria venture; 2023 [cited 2023 30 jan 2023]. Available from: https:\/\/www.mmv.org\/malaria-medicines\/lifecycle-malaria-parasite"},{"key":"cit0007","volume-title":"Best of British: how british-backed science can accelerate the end of malaria","author":"MNM UK","year":"2021"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b01105"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-021-00266-5"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1962291"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.876282"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33403-9"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01481-21"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1669415"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00442-X"},{"key":"cit0016","unstructured":"Trials C Safety, immunogenicity and efficacy of R21 matrix-M in 5-17 month old children in nanoro, Burkina Faso 2019 [cited 2023 Feb 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03896724"},{"key":"cit0017","unstructured":"Trials C 2023 [cited 2023 Feb 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=R21&cntry=&state=&city=&dist="},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S265602"},{"key":"cit0019","unstructured":"MMV. 50 active partners in MMV\u2019s network, working to help defeat malaria 2021. [cited 2023 Mar 1]; Available from: https:\/\/www.mmv.org\/our-impact\/achievements\/150-active-partners-mmvs-network-working-help-defeat-malaria"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25153409"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2021.01.009"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210803152419"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27010319"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2049239"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2220-1"},{"key":"cit0026","unstructured":"Kurtis J, Oleinikov AV, Raj D, inventors. Compositions and methods for the treatment of plasmodium falciparum malaria patent WO2022\/183111 A1. 2022."},{"key":"cit0027","unstructured":"WAIDYARACHCHI SL, Nguyen ST, DING X, et al., inventors. Compounds and methods for treating malaria patent WO2022159649A1. 2022."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/Ec.4.12.2153-2159.2005"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2004.11.001"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01181-18"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004026"},{"key":"cit0032","unstructured":"Sambasivam G, Gavara GR, Potluri V, et al., inventors. Treatment of malaria using histone deacetylase (hdac) inhibitors patent WO2021090194A1. 2021."},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2014.12.015"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-391"},{"key":"cit0035","unstructured":"TORTORELLA MD, Chen X, L DAI, et al., inventors. Pyrrolidine compounds for the treatment of malaria patent WO2020\/107189 A1. 2020."},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1803-1806.2004"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001897"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3061"},{"key":"cit0039","unstructured":"KHAN TA, Cumming JN, Olsen DB, et al., inventors. Compounds for the treatment of malaria patent WO2017142821A1. 2017."},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.23.9114"},{"key":"cit0041","unstructured":"KAMCHONWONGPAISON S, CHAROENSETAKUL N, PEEWASAN K, et al., inventors. 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against plasmodium falciparum patent WO2017052479A1. 2017."},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204556109"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501747102"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001138"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5433.1573"},{"key":"cit0046","unstructured":"Odom A, O\u2019Neill P, Berry N. inventors. Treatment of malaria using inhibitors of the ispd enzyme in the non-mevalonate pathway patent US20160046651A1. 2016."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2018.07.011"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151677"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79052-0"},{"key":"cit0050","unstructured":"OLIVIERI A, PAONE S, TIRELLI V, et al., inventors. Inhibitor compounds of the human GTPase Rac1 for use in the treatment of malaria patent WO2019122981A1. 2019."},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01498-21"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00728"},{"key":"cit0053","unstructured":"SETUA S, Mota MMDD, ENGUITA FJ, et al., inventors. Anti malarial compounds patent US 2022\/0211698 A1. 2022."},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1021\/ci049714+"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.74"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0054-x"},{"key":"cit0057","unstructured":"BRIZUELA AES, LORENZO EEC, Bosch J, inventors. Compounds with antimalarial activity patent WO2020\/209932 A1. 2020."},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1110\/ps.051891106"},{"key":"cit0059","unstructured":"Serrano-Brizuela AE, Col\u00f3n-Lorenzo EE, Bosh J, et al., inventors. Inhibitors of the malarial GST patent US 10,744,119 B1. 2020."},{"key":"cit0060","unstructured":"Gerwick W, VERDUGO BB, O\u2019donoghue A, et al., inventors. Immunoproteasome inhibitor patent WO2018\/213263 A1. 2018."},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201200007"},{"key":"cit0062","unstructured":"Krollenbrock A, Riscoe MK, inventors. Robenidine analogs as potent antimalarials against drug, inventors. Robenidine analogs as potent antimalarials against drugresistant plasmodium falciparum patent US2022\/0267258 A1. 2022."},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1126\/science.168.3929.373"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0449"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1128\/Aac.49.7.2857-2864.2005"},{"key":"cit0066","unstructured":"KNAPP S, BARROWS RD, Guy RK, et al., inventors. Compositions and methods for treating malaria patent WO2021\/167894 A1. 2021."},{"key":"cit0067","unstructured":"FAYAD AA, HERRMANN J, JUNGMANN K, et al., inventors. Chlorotonil derivatives patent WO2019\/092030 A1. 2019."},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03326-14"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200703993"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/s0020-7519(96)00152-x"},{"key":"cit0071","unstructured":"Manetsch R, Kyle DE, Neelarapu R, et al., inventors. Quinolone-based compounds, formulations, and uses thereof patent US10,000,452 B1. 2018."},{"key":"cit0072","unstructured":"Vennerstrom JL, Dong Y, Charman SA, et al., inventors. Dispiro 1,2,4-trioxolane antimalarials patent WO2009058859A2. 2009."},{"key":"cit0073","unstructured":"Vennerstrom JL, Dong Y, Charman SA, et al., inventors. Spiro and dispiro 1,2,4-trioxolane antimalarials patent WO2009091433A2. 2009."},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015762108"},{"key":"cit0075","unstructured":"Vennerstrom JL, Charman SA, inventors. New anti-malarial agent patent WO2018\/069420 A1. 2018."},{"key":"cit0076","unstructured":"REDDY DS, Shanmugam D, RAMESH R, et al. Silicon based cyclic compounds and pharmaceutical compositions for treating malaria and toxoplasmosis patent WO2017\/141272 A1. 2017. inventors"},{"key":"cit0077","unstructured":"EISOHLY MA, Gul W, inventors. Selected artemisinin dimers for the treatment of lashmaniasis patent WO2020176488A1. 2020."},{"key":"cit0078","unstructured":"Lin G, ZHAN W, Zhang H, et al., inventors. Artemisinin-proteasome inhibitor conjugates and their use in the treatment of disease patent WO2022159581A2. 2022."},{"key":"cit0079","unstructured":"Bhattacharya AK, ARATIKATLA EK, Malhotra P, et al., inventors. Novel antimalarial compounds, process for preparation and their use for drug resistant malaria patent WO2019\/202609. 2019."},{"key":"cit0080","unstructured":"Zhao M, Zhou L-M, inventors. Artemisinin-derived trimers and tetramers and their use thereof patent WO2019\/104247. 2019."},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06221-1"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau1458"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.670775"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.805482"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020115"},{"key":"cit0086","unstructured":"Hill AVS, Ewer K, inventors. Malaria vaccine WO2019021013 A1. 2019."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2023.2203814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T14:15:13Z","timestamp":1683209713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2023.2203814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/13543776.2023.2203814"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2023.2203814","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}